Clinical Trial Update: Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating subcutaneous atezolizumab for non-small cell lung cancer, sponsored by the University of Southern California, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: University of Southern California | Conditions: Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING